Refine Results
  1. "European Urology"
Formats
  1. Journal Article (410)
  2. Editorial (19)
  3. Correspondence (15)
  4. Conference Paper (8)
  5. Review (7)
  6. Meeting Abstract (4)
  7. Research Letter (3)
  8. Guidelines (2)
Groups
  1. Urology (277)
  2. Surgery (264)
  3. Population Sciences Research Program (127)
  4. Epidemiology and Biostatistics (119)
  5. Health Outcomes Research Group (83)
  6. Department of Medicine (81)

More Groups

People
  1. Andrew Vickers (81)
  2. James Eastham (50)
  3. Harry Herr (44)
  4. Karim Touijer (42)
  5. Bernard Bochner (38)
  6. Peter Scardino (35)

More People

Years
  1. 2022 (2)
  2. 2021 (19)
  3. 2020 (30)
  4. 2019 (27)
  5. 2018 (26)
  6. 2017 (25)

More Years

Publications
  1. European Urology (468)
Publishers
  1. Elsevier Science, Inc. (468)

Results (468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Race, biology, disparities, and prostate cancer
    Editorial

    Vickers, A. J.; Elfiky, A.; Freeman, V. L.; Roach, M. 3rd
    European Urology (2022)

    Fulltext@MSK | Save
  • Health-related quality of life of patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin after platinum and PD-1/PD-L1 inhibitor therapy: Results from cohort 1 of the phase 2 EV-201 clinical trial
    Journal Article

    McGregor, B.; O'Donnell, P. H.; Balar, A.; Petrylak, D.; Rosenberg, J.; Yu, E. Y.; Quinn, D. I.; Heath, E. I.; Campbell, M.; Hepp, Z.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's letter to the editor re: Andrew J. Vickers. Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer. Eur Urol 2021;80:567–72
    Correspondence

    Vickers, A. J.
    European Urology (2021)

    Fulltext@MSK | Save
  • Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer
    Journal Article

    Vickers, A. J.
    European Urology (2021)

    Fulltext@MSK | Save
  • Health-related quality of life with adjuvant nivolumab vs. placebo after radical resection for high-risk muscle-invasive urothelial carcinoma: Results from the phase 3 checkmate 274 trial
    Meeting Abstract

    Gschwend, J. E.; Bajorin, D.; Galsky, M.; Broughton, E.; Braverman, J.; Koon, H.; Maira-Arce, M.; Hamilton, M.; Shi, L.; Guo, S.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Long-term predictive value of serum PSA values obtained in clinical practice - Results from the Norwegian Prostate Cancer Consortium (NPCC)
    Meeting Abstract

    Carlsson, S.; Bjerner, J.; Lilja, H.; Aas, K.; Fosså, S. D.; Müller, C.; Müller, S.; Stensvold, A.; Thomas, O.; Røe, O. D.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups
    Meeting Abstract

    Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Patient perspective on serving on the steering committee of the AURORAX-0087A trial for non-metastatic clear cell renal cell carcinoma
    Meeting Abstract

    Giles, R.; Nair, R.; Azawi, N. H.; Barber, N.; Bex, A.; Campi, R.; Capitanio, U.; Gatto, F.; Hakimi, A. A.; Järvinen, P.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Defining resistance to immune checkpoint inhibitors in urothelial carcinoma: Insights from PURE-01
    Editorial

    Clinton, T. N.
    European Urology (2021)

    Fulltext@MSK | Save
  • The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: Implications in diagnosis and management
    Journal Article

    Weng, S.; DiNatale, R. G.; Silagy, A.; Mano, R.; Attalla, K.; Kashani, M.; Weiss, K.; Benfante, N. E.; Winer, A. G.; Coleman, J. A.; more...
    European Urology (2021)

    Fulltext@MSK | Save